US 8367660
Modulators of cystic fibrosis transmembrane conductance regulator
granted A61KA61K31/538A61K31/5415
Quick answer
US patent 8367660 (Modulators of cystic fibrosis transmembrane conductance regulator) held by Vertex Pharmaceuticals Incorporated expires Mon Jan 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Feb 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/538, A61K31/5415, A61K45/06, A61P